General FAQs

A: Hyflux was founded in 1989 as Hydrochem (S) Pte Ltd with a start-up capital of S$20,000 and three staff.

A: Hyflux was listed on 17 January 2001. Hyflux shares trade on the main board of the Singapore Stock Exchange (SGX-ST).

A: The offer price was S$0.32 per ordinary share at IPO on 17 January 2001.

A: An American Depositary Receipt (ADR) is a US dollar denominated negotiable certificate issued by a U.S. depositary bank to represent ownership of shares in a non-US company. We neither authorise nor do we support or encourage the establishment of any ADR programme in respect of our securities. We disclaim any liability in connection with any unsponsored ADRs.

A: Hyflux ordinary shares trade under the stock symbol 600.

A: Hyflux shares can only be purchased through a licensed stockbroker with SGX-ST.

A: You may access our current stock quote here.

A: Since incorporation, Hyflux has had four bonus issues of ordinary shares.

Date of Announcement Type
4 November 2010 One for two
23 February 2005 One for two
28 August 2003 One for four
28 March 2002 One for four

A: As at 14 March 2016, our founder, Executive Chairman and Group CEO Olivia Lum holds 34.05% of Hyflux's shares. The rest of Hyflux's shares are widely held by global institutional funds and retail investors.

A: Hyflux issued a 6% p.a perpetual capital securities on 30 May 2016 and a 6% p.a. Class A cumulative preference shares on 25 April 2011. The perpetual capital securities and Class A cumulative preference shares are listed on the Mainboard of the SGX-ST under the stock symbols of BTWZ and N2H respectively.

A: You may view our past annual reports online at Annual Reports section.

If you would like to obtain a hardcopy of our latest annual report, please write in to:

Hyflux Ltd
Hyflux Innovation Centre
80 Bendemeer Road
Singapore 339949
Or e-mail at investor@hyflux.com.

A: Our financial year-end is on 31 December.

A: Our financial results are released every quarter in the months of February, May, August and November. Please view our Financial Calendar for the information.

A: Past financial results including presentation slides can be found at the Financial Results section.

A: The Hyflux Board of Directors balances the need for a satisfactory return to shareholders against the company's investment needs to ensure sustainable growth.

Hyflux has declared first and final dividends on its ordinary shares every year since 2004. The Group started distributing interim dividends on its ordinary shares from 2010. This means that Hyflux has started paying dividends on its ordinary shares twice a year from 2010.

Hyflux will pay the dividends to The Central Depository (Pte) Limited (CDP) which will, in turn, distribute the dividend entitlements to shareholders.

CDP maintains the registrar of shareholders' information for all companies listed on the SGX-ST. You must contact CDP directly for changes in your personal particulars:

The Central Depository (Pte) Limited
9 North Buona Vista Drive
#01-19/20 The Metropolis
Singapore 138588
Tel: (65) 6535 7511
Fax: (65) 6535 0775
E-mail: asksgx@sgx.com

A: Please view our Dividend History for the information.

Additional FAQs Read More

The weak power market in Singapore has contributed adversely to our financials, similar to our peers in the power generation sector. The oversupply of gas in the market has led to weak electricity prices. This is an industry wide issue affecting all power generation companies and is expected to persist in the near term, although the outlook for the power sector is expected to be positive in the long run.

In line with our asset light strategy, Hyflux is in the process of partially divesting Tuaspring Integrated Water and Power plant in Singapore as well as divesting the Tianjin Dagang Desalination Plant in China. We are unable to comment on the completion timeline as the progress of divestment of the two plants are ongoing. Any progress and updates will be announced accordingly in a timely manner.

The most recent disbursement of dividend for the Hyflux 6% Cumulative Preference Shares was on 25 October 2017 as per our announcement released on 21 September 2017 (http://investors.hyflux.com/news.html/id/604160). Hyflux has fulfilled all our interest payments and redemptions in a timely manner. As shared during our annual general meeting earlier this year in April 2017, one of the uses of the proceeds from the divestment of Tuaspring Integrated Water and Power Plant in Singapore and Tianjin Dagang Desalination plant in China will be the redemption of bonds and capital securities.

Included within the Hyflux Group is a relatively small but fast-growing consumer business, structured under the Hyfluxshop Group. The principal activities, business strategies and future plans of the Hyfluxshop Group are focused on the health and wellness segment, and are therefore distinctly different from the Group’s municipal and industrial segments. The Hyfluxshop Group offers a full suite of health and wellness consumer solutions to provide clean drinking water, enhance health and wellness with oxygen-rich water as well as provide nutritional supplements to complement the modern lifestyle.

In order to maximise the growth of the Hyfluxshop Group, it is necessary to provide dedicated management focus and attract talent with skillsets and mindset which are different from those existing within our main infrastructure business. Hyflux is thus proposing to undertake a dividend in specie of the Hyfluxshop Group to shareholders where subsequent listing of the Hyfluxshop Group will further unlock value for shareholders.

Hyflux is a leader in the seawater desalination industry, ranking among the top ten industry players consistently according to Global Water Intelligence 2017.

The Qurayyat Independent Water Project (IWP) project in Oman is in the final stages of testing and commissioning. Construction of the TuasOne WTE project in Singapore is on track. Contract negotiations for the Ain Sokhna Integrated Water and Power Project in Egypt, which is converting from an Engineering, Procurement, and Construction (EPC) to a Build, Operate and Transfer structure, is in progress.

In addition, the Group launched its flagship ELO Water Therapy Centre at Belvedere Close, in central Singapore which is a significant milestone for the Group’s consumer business.

All future plans and progress updates will be announced when available. You may wish to subscribe to our mailing list to be informed of the latest news at the following link: http://investors.hyflux.com/contacts.html